Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...
His work as a medical researcher has been global and is credited with saving hundreds of thousands of lives. He’s taught nearly 3,000 medical students. And his legacy of service to his fellow man will ...
Upright officers may feel isolated as unethical behaviour becomes normalised and practicality is confused with compromise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results